Marsha A Raebel

发表

Validity of Privacy-Protecting Analytical Methods That Use Only Aggregate-Level Information to Conduct Multivariable-Adjusted Analysis in Distributed Data Networks

Mia Gallagher, Xiaojuan Li, Bruce H Fireman, 2018, American journal of epidemiology.

ADHD medications and risk of serious cardiovascular events in young and middle-aged adults.

Bruce H Fireman, Marsha A Raebel, Sascha Dublin, 2011, JAMA.

Improving laboratory monitoring of medications: an economic analysis alongside a clinical trial.

Steven R Simon, Marsha A Raebel, Nancy A Perrin, 2009, The American journal of managed care.

Implications of different laboratory-based incident diabetic kidney disease definitions on comparative effectiveness studies.

Julie A Schmittdiel, Marsha A Raebel, Katherine M Newton, 2014, Journal of comparative effectiveness research.

Cluster Randomized Trials: Opportunities and Barriers Identified by Leaders of Eight Health Plans

Richard Platt, Marsha A Raebel, Kathleen M Mazor, 2007, Medical care.

Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study

Fang Zhang, Marsha A Raebel, Brian K Ahmedani, 2014, BMJ : British Medical Journal.

Monitoring of drugs with a narrow therapeutic range in ambulatory care.

Robert L Davis, Steven R Simon, Richard Platt, 2006, The American journal of managed care.

Randomized Trial to Improve Prescribing Safety in Ambulatory Elderly Patients

Nikki M. Carroll, Marsha A Raebel, D. Magid, 2007, Journal of the American Geriatrics Society.

Evaluation of gestational age and admission date assumptions used to determine prenatal drug exposure from administrative data

Marsha A Raebel, S. Andrade, M. Raebel, 2005, Pharmacoepidemiology and drug safety.

Randomized Trial to Improve Laboratory Safety Monitoring of Ongoing Drug Therapy in Ambulatory Patients

Julia A. Kelleher, Marsha A Raebel, D. Magid, 2006, Pharmacotherapy.

Stakeholders' views on data sharing in multicenter studies.

Mia Gallagher, Jeffrey R Curtis, David E Arterburn, 2017, Journal of comparative effectiveness research.

Compliance with Dosing Guidelines in Patients with Chronic Kidney Disease

Marsha A Raebel, D. Magid, M. Raebel, 2004, The Annals of pharmacotherapy.

Health services use and health care costs of obese and nonobese individuals.

Marsha A Raebel, Daniel C Malone, Stanley Xu, 2004, Archives of internal medicine.

Improved therapeutic monitoring with several interventions: a randomized trial.

Steven R Simon, Marsha A Raebel, N. Perrin, 2006, Archives of internal medicine.

Improving Prescribing Safety in Patients with Renal Insufficiency in the Ambulatory Setting: The Drug Renal Alert Pharmacy (DRAP) Program

Nikki M. Carroll, Marsha A Raebel, D. Magid, 2011, Pharmacotherapy.

Design considerations, architecture, and use of the Mini‐Sentinel distributed data system

Marsha A Raebel, Robert Rosofsky, Lesley H Curtis, 2012, Pharmacoepidemiology and drug safety.

Improving laboratory monitoring at initiation of drug therapy in ambulatory care: a randomized trial.

Julia A. Kelleher, Marsha A Raebel, D. Magid, 2005, Archives of internal medicine.

Measurement of Adherence in Pharmacy Administrative Databases: A Proposal for Standard Definitions and Preferred Measures

Marsha A Raebel, Daniel C Malone, D. Malone, 2006, The Annals of pharmacotherapy.

Baseline Laboratory Monitoring of Cardiovascular Medications in Elderly Health Maintenance Organization Enrollees

Robert L Davis, Steven R Simon, Marsha A Raebel, 2005, Journal of the American Geriatrics Society.

Validity of gout diagnoses in administrative data.

Hassan Fouayzi, Richard Platt, Marsha A Raebel, 2007, Arthritis and rheumatism.

Super learning to hedge against incorrect inference from arbitrary parametric assumptions in marginal structural modeling.

Patrick J O'Connor, Romain Neugebauer, Marsha A Raebel, 2013, Journal of clinical epidemiology.

FDA drug prescribing warnings: is the black box half empty or half full?

Robert L Davis, Richard Platt, Marsha A Raebel, 2006, Pharmacoepidemiology and drug safety.

Missing laboratory results data in electronic health databases: implications for monitoring diabetes risk.

Jason Roy, Marsha A Raebel, Kevin Haynes, 2017, Journal of comparative effectiveness research.

Potential Drug–Drug Interactions in the Outpatient Setting

Richard Platt, Marsha A Raebel, John R Horn, 2006, Medical Care.

Evaluation of propensity scores, disease risk scores, and regression in confounder adjustment for the safety of emerging treatment with group sequential monitoring

Andrea J Cook, Jason Roy, Marsha A Raebel, 2016, Pharmacoepidemiology and drug safety.

Prescription drug use in pregnancy.

Robert L Davis, Richard Platt, Marsha A Raebel, 2004, American journal of obstetrics and gynecology.

Drug safety data mining with a tree‐based scan statistic

Robert L Davis, Richard Platt, Marsha A Raebel, 2013, Pharmacoepidemiology and drug safety.

Utilizing data consortia to monitor safety and effectiveness of biosimilars and their innovator products.

Marsha A Raebel, Brenda Motheral, Gurvaneet Randhawa, 2015, Journal of managed care & specialty pharmacy.